Prestige BioPharma Limited financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

프레스티지바이오파마KRX:950210 · KOSPI · Healthcare

₩6,180+0.49%

2026-10-02 close

Prestige BioPharma Limited's 2025 annual results accompany close-price data dated 2026-10-02. 2025 revenue was KRW 10.22M. 2025 operating profit was −KRW 48.03M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy